These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 723350)
1. [Immunotherapy of melanoma (proceedings)]. Bolund C Lakartidningen; 1978 Dec; 75(49):4598. PubMed ID: 723350 [No Abstract] [Full Text] [Related]
2. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)]. Rundenstam CM Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339 [No Abstract] [Full Text] [Related]
3. [Use of immunotherapy in the treatment of malignant melanoma of the skin]. Kristensen E Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215 [No Abstract] [Full Text] [Related]
4. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis]. Wolf M; Menzel W Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658 [No Abstract] [Full Text] [Related]
5. [Immunotherapy of malignant melanomas]. Macher E Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638 [No Abstract] [Full Text] [Related]
6. [Current aspects of melanoma research. II. Immunotherapy]. Wätzig V Dermatol Monatsschr; 1977 May; 163(5):359-66. PubMed ID: 881082 [No Abstract] [Full Text] [Related]
7. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma. Dandapat MC; Mohapatra SK; Patra SK Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124 [No Abstract] [Full Text] [Related]
8. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V; Knopf B Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442 [TBL] [Abstract][Full Text] [Related]
9. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)]. Wätzig V; Knopf B Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550 [TBL] [Abstract][Full Text] [Related]
16. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection. Moff SL; Corey GR; Gottfredsson M Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816 [No Abstract] [Full Text] [Related]
17. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas]. Richter J; Duchková H; Kubíková M Cas Lek Cesk; 1975 Sep; 114(39):1201-3. PubMed ID: 1182748 [No Abstract] [Full Text] [Related]
18. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin. MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200 [TBL] [Abstract][Full Text] [Related]
19. Cromolyn prevents bronchospastic attacks caused by Bacillus Calmette Geurin immunotherapy for malignant melanoma patient. Wishnitzer R; Eliraz A; Fink A Ann Allergy; 1985 Aug; 55(2):167-9. PubMed ID: 3927789 [TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas]. Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444 [No Abstract] [Full Text] [Related] [Next] [New Search]